Q2 2024 Holdings
Filed 2024-08-15 | 43 holdings | $359.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $35.7M | 2,049,172 | 9.9% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $32.3M | 3,004,199 | 9.0% |
| Blue OWL Capital Corporation(OBDC) | COM | 69121K104 | $31.4M | 2,045,070 | 8.7% |
| Klaviyo Inc(KVYO) | COM SER A | 49845K101 | $29.8M | 1,198,270 | 8.3% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $28.0M | 3,859,468 | 7.8% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $23.1M | 2,449,827 | 6.4% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $22.1M | 1,715,401 | 6.1% |
| Evercommerce Inc(EVCM) | COM | 29977X105 | $18.0M | 1,641,929 | 5.0% |
| Acelyrin Inc | COM | 00445A100 | $12.9M | 2,926,028 | 3.6% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $11.1M | 3,372,499 | 3.1% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $11.0M | 268,238 | 3.1% |
| Context Therapeutics Inc(CNTX) | COM | 21077P108 | $10.3M | 5,161,290 | 2.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $9.7M | 215,260 | 2.7% |
| Toast Inc(TOST) | CL A | 888787108 | $8.3M | 322,578 | 2.3% |
| E2open Parent Holdings Inc(ETWOGBP) | COM CL A | 29788T103 | $7.4M | 1,650,943 | 2.1% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $7.2M | 157,633 | 2.0% |
| Ikena Oncology Inc | COM | 45175G108 | $6.8M | 4,091,118 | 1.9% |
| Sagimet Biosciences Inc(SGMT) | COM SER A | 786700104 | $5.7M | 1,673,877 | 1.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $5.3M | 450,339 | 1.5% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.0M | 95,000 | 1.4% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.0M | 1,120,027 | 1.4% |
| Starwood Property Trust(STWD) | SHS | 85571B105 | $4.3M | 226,456 | 1.2% |
| Pyxis Oncology Inc(PYXS) | COMMON STOCK | 747324101 | $3.5M | 1,046,025 | 1.0% |
| Mereo Biopharma Group PLC(MREO) | SPON ADS | 589492107 | $3.2M | 897,809 | 0.9% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $3.0M | 1,140,000 | 0.8% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $2.8M | 2,829,712 | 0.8% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $2.3M | 733,568 | 0.6% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $2.2M | 1,055,882 | 0.6% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $2.2M | 55,000 | 0.6% |
| Immunovant Inc(IMVT) | COM | 45258J102 | $2.1M | 80,000 | 0.6% |
| Syros Pharmaceuticals Inc(SYRS) | COM NEW | 87184Q206 | $1.8M | 340,855 | 0.5% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $1.7M | 40,000 | 0.5% |
| Celcuity Inc(CELC) | COM | 15102K100 | $1.1M | 65,000 | 0.3% |
| Gohealth Inc(GOCO) | CL A NEW | 38046W204 | $814.6K | 83,264 | 0.2% |
| Blend Labs Inc(BLND) | CL A | 09352U108 | $682.7K | 289,270 | 0.2% |
| Engene Holdings Inc(ENGNW) | *W EXP 10/31/202 | 29286M113 | $608.3K | 51,177 | 0.2% |
| Plum Acquisition Corp III | UNIT 03/31/2028 | G63290129 | $324.0K | 70,000 | 0.1% |
| Desktop Metal Inc(DM*) | COM CL A | 25058X303 | $309.8K | 750,000 | 0.1% |
| Precision Biosciences Inc(DTIL) | COM NEW | 74019P207 | $196.7K | 20,220 | 0.1% |
| Geron Corporation(GERN) | COM | 374163103 | $101.4K | 23,918 | 0.0% |
| Plum Acquisition Corp III | *W EXP 03/31/202 | G63290103 | $46.7K | 666,666 | 0.0% |